Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals | Zendy

Minh Patrick Lê | Zendy; Linda Bélarbi | Zendy; MarieLaure Chaix | Zendy; Emmanuel Dulioust | Zendy; Nadia Mahjoub | Zendy; Dominique Salmon | Zendy; JeanPaul Viard | Zendy; Claudine Duvivier | Zendy; Gilles Peytavin | Zendy; Odile Launay | Zendy; Jade Ghosn | Zendy

Open Access

Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals

Author(s) -

Minh Patrick Lê,

Linda Bélarbi,

MarieLaure Chaix,

Emmanuel Dulioust,

Nadia Mahjoub,

Dominique Salmon,

JeanPaul Viard,

Claudine Duvivier,

Gilles Peytavin,

Odile Launay,

Jade Ghosn

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx275

Subject(s) - maraviroc , rilpivirine , raltegravir , medicine , virology , dolutegravir , human immunodeficiency virus (hiv) , antiretroviral drug , etravirine , antiretroviral therapy , viral load

Sub-optimal penetration of antiretroviral drugs in genital compartments might promote local HIV persistence and increase the risk of HIV transmission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research